RFM
AGN

Royal Fund Management’s Allergan plc AGN Stock Holding History

Royal Fund Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-8
Closed -$1K – 640
2020
Q1 		$1K Hold
8
– – ﹤0.01% 553
2019
Q4 		$1K Sell
8
-244
-97% -$44K ﹤0.01% 618
2019
Q3 		$42K Hold
252
– – 0.01% 251
2019
Q2 		$42K Hold
252
– – 0.01% 245
2019
Q1 		$36K Hold
252
– – 0.01% 238
2018
Q4 		$33K Buy
252
+244
+3,050% +$40K 0.01% 221
2018
Q3 		$1K Hold
8
– – ﹤0.01% 500
2018
Q2 		$1K Hold
8
– – ﹤0.01% 545
2018
Q1 		$1K Buy
+8
New +$1.34K ﹤0.01% 518
2017
Q3 		– Sell
-200
Closed -$48K – 548
2017
Q2 		$48K Hold
200
– – 0.02% 160
2017
Q1 		$47K Buy
+200
New +$46.6K 0.02% 158

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Royal Fund Management's AGN Position: Q2 2020 in Review

Royal Fund Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 8 shares — an estimated $1K sold.

Royal Fund Management first reported a position in AGN in Q1 2017 and held it in 11 quarters. The position peaked at $48K in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Royal Fund Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Royal Fund Management sold 8 Allergan plc shares in Q2 2020, an estimated $1K.
  • Royal Fund Management first reported a position in Allergan plc in Q1 2017 and held it in 11 quarters.
  • Royal Fund Management's Allergan plc position peaked at $48K in Q2 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Royal Fund Management's 13F filing for Q2 2020, filed 6 Aug 2020.